Related Experiment Videos
Canine cryptococcosis associated with prolonged corticosteroid therapy.
Summary
This report details the first documented case of canine cryptococcosis in Alberta, a fungal infection diagnosed in a five-year-old Irish Setter. The infection source remains undetermined, highlighting a rare occurrence in the region.
Area of Science:
- Veterinary Mycology
- Canine Infectious Diseases
Background:
- Cryptococcosis is a systemic fungal infection caused by encapsulated yeasts, primarily Cryptococcus neoformans and Cryptococcus gattii.
- Canine cryptococcosis is relatively uncommon but can present with diverse clinical signs, often affecting the respiratory tract, central nervous system, and skin.
Purpose of the Study:
- To document the first confirmed case of canine cryptococcosis in Alberta.
- To contribute to the understanding of cryptococcosis epidemiology in domestic animals within the region.
Main Methods:
- Diagnostic confirmation of cryptococcosis through laboratory analysis (details not provided in abstract).
- Review of veterinary diagnostic records from Alberta Veterinary Services Division (1961-1980).
Main Results:
- A single case of cryptococcosis was identified in a five and one half-year-old female Irish Setter.
- This represents the sole laboratory-confirmed case of canine cryptococcosis in Alberta between 1961 and 1980.
- The source of infection for the described case could not be determined.
Conclusions:
- Canine cryptococcosis is a rare but significant diagnosis in veterinary practice.
- This case underscores the importance of considering fungal infections in the differential diagnosis of canine diseases in Alberta.
- Further surveillance and case reporting are valuable for understanding the prevalence and distribution of such infections.
Related Concept Videos
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...